Muhammad Kashif

1.0k total citations · 2 hit papers
42 papers, 715 citations indexed

About

Muhammad Kashif is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Muhammad Kashif has authored 42 papers receiving a total of 715 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 7 papers in Hematology and 6 papers in Oncology. Recurrent topics in Muhammad Kashif's work include Multiple Myeloma Research and Treatments (5 papers), Computational Drug Discovery Methods (4 papers) and Protein Degradation and Inhibitors (4 papers). Muhammad Kashif is often cited by papers focused on Multiple Myeloma Research and Treatments (5 papers), Computational Drug Discovery Methods (4 papers) and Protein Degradation and Inhibitors (4 papers). Muhammad Kashif collaborates with scholars based in Pakistan, Sweden and China. Muhammad Kashif's co-authors include Martin O. Bergö, Haidong Yao, Clotilde Wiel, Mohamed X. Ibrahim, Chowdhury Arif Jahangir, Dorian V. Ziegler, Chandrasekhar Kanduri, Kristell Le Gal, Tanushree Ghosh and Tanmoy Mondal and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and SHILAP Revista de lepidopterología.

In The Last Decade

Muhammad Kashif

36 papers receiving 710 citations

Hit Papers

BACH1 Stabilization by Antioxidants Stimulates Lung Cance... 2019 2026 2021 2023 2019 2023 100 200 300 400

Peers

Muhammad Kashif
Peng Lyu China
Mohammad Azhar Aziz Saudi Arabia
Jing Zuo China
Xinbin Gu United States
Peng Lyu China
Muhammad Kashif
Citations per year, relative to Muhammad Kashif Muhammad Kashif (= 1×) peers Peng Lyu

Countries citing papers authored by Muhammad Kashif

Since Specialization
Citations

This map shows the geographic impact of Muhammad Kashif's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muhammad Kashif with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muhammad Kashif more than expected).

Fields of papers citing papers by Muhammad Kashif

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muhammad Kashif. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muhammad Kashif. The network helps show where Muhammad Kashif may publish in the future.

Co-authorship network of co-authors of Muhammad Kashif

This figure shows the co-authorship network connecting the top 25 collaborators of Muhammad Kashif. A scholar is included among the top collaborators of Muhammad Kashif based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muhammad Kashif. Muhammad Kashif is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cisowski, Jarosław, Ahmed E. El Zowalaty, Sama I. Sayin, et al.. (2025). BRAF inhibition increases TGFβ2 production and stimulates metastasis in mice with endogenous BRAF V600E -induced hepatocellular carcinoma. Proceedings of the National Academy of Sciences. 122(45). e2503044122–e2503044122.
2.
Kashif, Muhammad, et al.. (2025). Mapping neonatal vulnerability using the Small Vulnerable Newborn (SVN) framework—secondary analysis of PRISMA Pakistan study. The Lancet Regional Health - Southeast Asia. 33. 100535–100535.
3.
Kashif, Muhammad, et al.. (2024). ROLE OF AUTOLOGOUS NANOFAT GRAFTING IN THE TREATMENT OF POST ACNE AND POST BURN SCARRING OF THE FACE. Journal of Ayub Medical College Abbottabad. 36(3). 560–563. 1 indexed citations
4.
Shoaib, Muhammad, Amjad Islam Aqib, Noreen Majeed, et al.. (2023). MRSA compendium of epidemiology, transmission, pathophysiology, treatment, and prevention within one health framework. Frontiers in Microbiology. 13. 1067284–1067284. 89 indexed citations breakdown →
5.
Kashif, Muhammad, Uzma Khan, Fouzia Farooq, et al.. (2023). Cohort profile: the Pregnancy Risk Infant Surveillance and Measurement Alliance (PRISMA) – Pakistan. BMJ Open. 13(12). e078222–e078222. 3 indexed citations
6.
Nahi, Hareth, Katarina Uttervall, Sandra Lockmer, et al.. (2023). Minimal residual disease status is the prognostic determinant following high‐dose treatment for patients with multiple myeloma. Cancer Medicine. 12(22). 20736–20744. 2 indexed citations
7.
Kashif, Muhammad, Amar Nasir, Mazhar Abbas, et al.. (2023). Unlocking the anti‐diabetic potential of Gymnema sylvestre, Trigonella foenum‐graecum, and their combination thereof: An in‐vivo evaluation. Food Science & Nutrition. 11(12). 7664–7672. 6 indexed citations
9.
Islam, Md. Ashraful, Dhfer Alshayban, Atta Abbas Naqvi, et al.. (2023). How anxiety attributed to COVID-19, disease knowledge, and intention to vaccinate against SARS-CoV-2 viral infection prevail in general public of Saudi Arabia?. Frontiers in Public Health. 11. 1078023–1078023. 1 indexed citations
10.
Yao, Haidong, Xue Chen, Ting Wang, et al.. (2023). A MYC-controlled redox switch protects B lymphoma cells from EGR1-dependent apoptosis. Cell Reports. 42(8). 112961–112961. 2 indexed citations
11.
Chaireti, Roza, Katarina Uttervall, Johan Lund, et al.. (2022). Conditioning with melphalan 200 mg/m2 and subsequent ASCT improves progression‐free and overall survival in elderly myeloma patients compared to standard of care. European Journal Of Haematology. 109(6). 749–754. 3 indexed citations
12.
Kashif, Muhammad, et al.. (2022). Prevalence of Coccydynia Among Postpartum Women. Pakistan Journal of Health Sciences. 108–112. 3 indexed citations
13.
Susek, Katharina H., Mari Gilljam, Márton Keszei, et al.. (2022). Generation of NK cells with chimeric-switch receptors to overcome PD1-mediated inhibition in cancer immunotherapy. Cancer Immunology Immunotherapy. 72(5). 1153–1167. 11 indexed citations
14.
Chen, Xue, Haidong Yao, Muhammad Kashif, et al.. (2021). A small-molecule ICMT inhibitor delays senescence of Hutchinson-Gilford progeria syndrome cells. eLife. 10. 19 indexed citations
15.
Wiel, Clotilde, Kristell Le Gal, Mohamed X. Ibrahim, et al.. (2019). BACH1 Stabilization by Antioxidants Stimulates Lung Cancer Metastasis. Cell. 178(2). 330–345.e22. 427 indexed citations breakdown →
16.
Naveed, Muhammad, et al.. (2017). The Darkness Brings Light in the Field of Bio-Communication Through Melatonin Production. Advances in Applied Science Research. 8(1). 1 indexed citations
17.
Qureshi, M. Rizwan Jameel & Muhammad Kashif. (2017). Adaptive Framework to Manage Multiple Teams Using Agile Methodologies. International Journal of Modern Education and Computer Science. 9(1). 52–59. 5 indexed citations
18.
Kashif, Muhammad, Caroline Haglund, Karl F. Blom, et al.. (2016). Combination screening in vitro identifies synergistically acting KP372-1 and cytarabine against acute myeloid leukemia. Biochemical Pharmacology. 118. 40–49. 2 indexed citations
19.
Kashif, Muhammad, Claes Andersson, Sadia Hassan, et al.. (2015). In vitro discovery of promising anti-cancer drug combinations using iterative maximisation of a therapeutic index. Scientific Reports. 5(1). 14118–14118. 21 indexed citations
20.
Kashif, Muhammad, Claes Andersson, Magnus Åberg, et al.. (2014). A Pragmatic Definition of Therapeutic Synergy Suitable for Clinically Relevant In Vitro Multicompound Analyses. Molecular Cancer Therapeutics. 13(7). 1964–1976. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026